A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

NCT06092268 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-A2009 for injection ； Almonertinib Mesilate Tablets
DRUG: SHR-A2009 for injection；Adebrelimab Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.